National Health Investors, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $375.6M | $335.2M | $319.8M | $278.2M | $298.7M | $332.8M | $318.1M | $294.6M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $26.9M | $20.7M | $19.3M | $22.8M | $18.4M | $13.3M | $13.4M | $12.5M |
| Operating Income | — | — | — | — | — | — | $217.6M | $204.1M |
| Operating Margin | — | — | — | — | — | — | 68.4% | 69.3% |
| Interest Expense | $57.4M | $59.9M | $58.2M | $44.9M | $50.8M | $52.9M | $56.3M | $49.1M |
| Pretax Income | — | — | — | — | — | — | $161.3M | $155.1M |
| Income Tax Expense | — | — | — | — | — | — | — | $138.0K |
| Net Income | $142.2M | $138.0M | $135.7M | $66.4M | $111.8M | $185.1M | $160.5M | $154.3M |
| Net Margin | 37.9% | 41.2% | 42.4% | 23.9% | 37.4% | 55.6% | 50.4% | 52.4% |
| EPS (Basic) | $3.03 | $3.14 | $3.13 | $1.48 | $2.45 | $4.14 | $3.70 | $3.68 |
| EPS (Diluted) | $3.02 | $3.13 | $3.13 | $1.48 | $2.44 | $4.14 | $3.67 | $3.67 |
| Shares Outstanding (Basic) | 46.9M | 43.8M | 43.4M | 44.8M | 45.7M | 44.7M | 43.4M | 41.9M |
| Shares Outstanding (Diluted) | 47.1M | 44.1M | 43.4M | 44.8M | 45.7M | 44.7M | 43.7M | 42.1M |
| Dividends Per Share | $3.64 | $3.60 | $3.60 | $3.60 | $3.80 | $4.41 | $4.20 | $4.00 |